JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sorg, B. A.
Right arrow Articles by Prasad, B. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sorg, B. A.
Right arrow Articles by Prasad, B. M.

Vol. 281, Issue 1, 54-61, 1997

Repeated Daily Cocaine Alters Subsequent Cocaine-induced Increase of Extracellular Dopamine in the Medial Prefrontal Cortex1

Barbara A. Sorg, Debra L. Davidson, Peter W. Kalivas and Balakrishna M. Prasad

Program in Neuroscience, Department of Veterinary and Comparative Anatomy, Pharmacology and Physiology, Washington State University, Pullman, Washington

Male Sprague-Dawley rats that were naive or that had been treated with five daily saline or cocaine injections (15 mg/kg i.p.) were subsequently challenged with an injection of cocaine, and extracellular dopamine content in the medial prefrontal cortex (mPFC) was measured using in vivo microdialysis. Cocaine challenge increased extracellular dopamine levels from base line in all three groups of rats, but the augmentation was significantly reduced in the cocaine-pretreated group, compared with the saline-pretreated group. In contrast, mPFC dopamine levels were not different among groups after challenge with systemic d-amphetamine. To test whether repeated cocaine treatment led to altered releasability of dopamine from mPFC terminals, challenge with KCl (10, 30 or 100 mM) or d-amphetamine (3, 30 or 300 µM) was made via infusion through the dialysis probe into the mPFC. No differences in dopamine levels were found between treatment groups for either drug at any dose. To determine whether the effects of cocaine were mediated by local actions within mPFC dopamine terminals, a cocaine challenge was administered through the microdialysis probe (1, 10 or 100 µM). In contrast to the systemic cocaine challenge, local infusion of cocaine elicited a significant increase in daily cocaine-pretreated rats, compared with saline-pretreated controls, at the lowest dose tested, with no differences at the higher two doses. In summary, daily cocaine-pretreated rats demonstrated a suppressed mPFC dopamine response to subsequent systemic, but not local, cocaine challenge. The results suggest that this apparent tolerance is not due to altered releasability of dopamine from mPFC terminals and may rely on altered afferent regulation of mesocortical dopamine neurons.

Copyright © by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 J. Neurosci.Home page
L. Orozco-Cabal, J. Liu, S. Pollandt, K. Schmidt, P. Shinnick-Gallagher, and J. P. Gallagher
Dopamine and Corticotropin-Releasing Factor Synergistically Alter Basolateral Amygdala-to-Medial Prefrontal Cortex Synaptic Transmission: Functional Switch after Chronic Cocaine Administration
J. Neurosci., January 9, 2008; 28(2): 529 - 542.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
H. Homayoun and B. Moghaddam
Progression of Cellular Adaptations in Medial Prefrontal and Orbitofrontal Cortex in Response to Repeated Amphetamine
J. Neurosci., August 2, 2006; 26(31): 8025 - 8039.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
E. B. Margolis, H. Lock, V. I. Chefer, T. S. Shippenberg, G. O. Hjelmstad, and H. L. Fields
{kappa} opioids selectively control dopaminergic neurons projecting to the prefrontal cortex
PNAS, February 21, 2006; 103(8): 2938 - 2942.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
F. J. Nasif, K. Sidiropoulou, X.-T. Hu, and F. J. White
Repeated Cocaine Administration Increases Membrane Excitability of Pyramidal Neurons in the Rat Medial Prefrontal Cortex
J. Pharmacol. Exp. Ther., March 1, 2005; 312(3): 1305 - 1313.
[Abstract] [Full Text] [PDF]

Home page
 Cereb CortexHome page
C. E. Beyer and J. D. Steketee
Cocaine Sensitization: Modulation by Dopamine D2 Receptors
Cereb Cortex, May 1, 2002; 12(5): 526 - 535.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
B. A. Sorg, N. Li, and W.-R. Wu
Dopamine D1 Receptor Activation in the Medial Prefrontal Cortex Prevents the Expression of Cocaine Sensitization
J. Pharmacol. Exp. Ther., April 12, 2001; 297(2): 501 - 508.
[Abstract] [Full Text]

Home page
 J. Neurosci.Home page
H. K. Wayment, J. O. Schenk, and B. A. Sorg
Characterization of Extracellular Dopamine Clearance in the Medial Prefrontal Cortex: Role of Monoamine Uptake and Monoamine Oxidase Inhibition
J. Neurosci., January 1, 2001; 21(1): 35 - 44.
[Abstract] [Full Text] [PDF]

Home page
 Cereb CortexHome page
T. M. Tzschentke and W. J. Schmidt
Differential Effects of Discrete Subarea-specific Lesions of the Rat Medial Prefrontal Cortex on Amphetamine- and Cocaine-induced Behavioural Sensitization
Cereb Cortex, May 1, 2000; 10(5): 488 - 498.
[Abstract] [Full Text] [PDF]

Home page
 J PsychopharmacolHome page
P. W. Kalivas, R. Chris Pierce, J. Cornish, and B. A. Sorg
A role for sensitization in craving and relapse in cocaine addiction
J Psychopharmacol, January 1, 1998; 12(1): 49 - 53.
[Abstract] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1997 by the American Society for Pharmacology and Experimental Therapeutics.